Treatment of experimental esophagogastric myotomy with bone marrow mesenchymal stem cells in a rat model

Neurogastroenterology and Motility

Volumn 25, Issue 10, 2013, Pages

  Mazzanti, B ^a   Lorenzi, B ^b   Lorenzoni, P ^b   Borghini, A ^b   Boieri, M ^a   Lorenzi, M ^b   Santosuosso, M ^c   Bosi, A ^a   Saccardi, R ^a,c   Weber, E ^b   Pessina, F ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Achalasia; Esophagogastric myotomy; Lower esophageal sphincter; Mesenchymal stem cells; Muscle regeneration

Indexed keywords

GREEN FLUORESCENT PROTEIN; METHACRYLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW; CONTROLLED STUDY; ESOPHAGUS MYOTOMY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LOWER ESOPHAGUS SPHINCTER; MALE; MESENCHYMAL STEM CELL; MORPHOMETRICS; MUSCLE CONTRACTION; MUSCLE REGENERATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SMOOTH MUSCLE;

ACHALASIA; ESOPHAGOGASTRIC MYOTOMY; LOWER ESOPHAGEAL SPHINCTER; MESENCHYMAL STEM CELLS; MUSCLE REGENERATION;

ANIMALS; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; ESOPHAGEAL SPHINCTER, LOWER; ESOPHAGOGASTRIC JUNCTION; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE, SMOOTH; RATS; RATS, INBRED LEW; REGENERATION;

EID: 84884729449     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12182     Document Type: Article

References (34)

1. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98: 1076-84.
2. Drost AC, Weng S, Feil G et al. In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair. Ann N Y Acad Sci 2009; 1176: 135-43.
3. Santa María L, Rojas CV, Minguell JJ. Signals from damaged but not undamaged skeletal muscle induce myogenic differentiation of rat bone-marrow-derived mesenchymal stem cells. Exp Cell Res 2004; 300: 418-26.
4. Wang T, Xu Z, Jiang W, Ma A. Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int J Cardiol 2006; 109: 74-81.
5. Imamura T, Ishizuka O, Kinebuchi Y et al. Implantation of autologous bone-marrow-derived cells reconstructs functional urethral sphincters in rabbits. Tissue Eng Part A 2011; 17: 1069-81.
6. Kinebuchi Y, Aizawa N, Imamura T, Ishizuka O, Igawa Y, Nishizawa O. Autologous bone-marrow-derived mesenchymal stem cell transplantation into injured rat urethral sphincter. Int J Urol 2010; 17: 359-68.
7. Lorenzi B, Pessina F, Lorenzoni P et al. Treatment of experimental injury of anal sphincters with primary surgical repair and injection of bone marrow-derived mesenchymal stem cells. Dis Colon Rectum 2008; 51: 411-20.
8. Salcedo L, Mayorga M, Damaser M et al. Mesenchymal stem cells can improve anal pressures after anal sphincter injury. Stem Cell Res 2012; 10: 95-102.
9. Pathi SD, Acevedo JF, Keller PW et al. Recovery of the injured external anal sphincter after injection of local or intravenous mesenchymal stem cells. Obstet Gynecol 2012; 119: 134-44.
10. Nikolavsky D, Chancellor MB. Stem cell therapy for stress urinary incontinence. Neurourol Urodyn 2012; 29(Suppl. 1): S36-41.
11. Rodríguez LV, Alfonso Z, Zhang R, Leung J, Wu B, Ignarro LJ. Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci U S A 2006; 103: 12167-72.
12. Fascetti-Leon F, Malerba A, Boldrin L et al. Murine muscle precursor cells survived and integrated in a cryoinjured gastroesophageal junction. J Surg Res 2007; 143: 253-9.
13. Pasricha PJ, Ahmed I, Jankowski RJ, Micci MA. Endoscopic injection of skeletal muscle-derived cells augments gut smooth muscle sphincter function: implications for a novel therapeutic approach. Gastrointest Endosc 2009; 70: 1231-7.
14. Richter JE. Achalasia-an update. J Neurogastroenterol Motil 2010; 16: 232-42.
15. Campos GM, Vittinghoff E, Rabl C et al. Endoscopic and surgical treatments for achalasia. A systematic review and meta-analysis. Ann Surg 2009; 249: 45-57.
16. Swanström LL, Kurian A, Dunst CM, Sharata A, Bhajani N, Rieder E. Long term outcomes of an endoscopic myotomy for achalasia. The POEM procedure. Ann Surg 2012; 256: 659-67.
17. Farré R, Wang XY, Vidal E et al. Interstitial cells of Cajal and neuromuscular transmission in the rat lower oesophageal sphincter. Neurogastroenterol Motil 2007; 19: 484-96.
18. Kawahara H, Blackshaw LA, Lehmann A, Dent J. Responses of the rat lower oesophageal sphincter (LOS) to vagal efferent activation. Neurogastroenterol Motil 1997; 9: 85-97.
19. Peyromaure M, Sebe P, Praud C et al. Fate of implanted syngenic muscle precursor cells in striated urethral sphincter of female rats: perspectives for treatment of urinary incontinence. Urology 2004; 64: 1037-41.
20. Biérinx AS, Sebille A. The fate of implanted syngenic muscle precursor cells in injured striated urethral sphincter of female rats. Cell Transplant 2008; 17: 1193-8.
21. Carr LK, Steele D, Steele S et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 881-3.
22. Frudinger A, Kölle D, Schwaiger W, Pfeifer J, Paede J, Halligan S. Muscle-derived cell injection to treat anal incontinence due to obstetric trauma: pilot study with 1 year follow-up. Gut 2010; 59: 55-61.
23. Goldman HB, Sievert KD, Damaser MS. Will we ever use stem cells for the treatment of SUI? ICI-RS 2011. Neurourol Urodyn 2012; 31: 386-9.
24. White AB, Keller PW, Acevedo JF, Word RA, Wai CY. Effect of myogenic stem cells on contractile properties of the repaired and unrepaired transected external anal sphincter in an animal model. Obstet Gynecol 2010; 115: 815-23.
25. Francis DL, Katzka DA. Achalasia: update on the disease and its treatment. Gastroenterology 2010; 139: 369-74.
26. Farre R, Auli M, Lecea B, Martinez E, Clave P. Pharmacologic charaterisation of intrinsic mechanisms controlling tone and relaxation of porcine lower esophageal sphincter. J Pharmacol Exp Ther 2006; 316: 1238-48.
27. Imamura T, Kinebuchi Y, Ishizuka O, Seki S, Igawa Y, Nishizawa O. Implanted mouse bone marrow-derived cells reconstruct layered smooth muscle structures in injured urinary bladders. Cell Transplant 2008; 17: 267-78.
28. Kanematsu A, Yamamoto S, Iwai-Kanai E et al. Induction of smooth cell-like phenotype in marrow-derived cells among regenerating urinary bladder smooth muscle cells. Am J Pathol 2005; 166: 565-73.
29. Sharma AK, Bury MI, Marks AJ et al. A nonhuman primate model for urinary bladder regeneration using autologous sources of bone marrow-derived mesenchymal stem cells. Stem Cells 2011; 29: 241-50.
30. Corcos J, Loutochin O, Campeau L et al. Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinence. Neurourol Urodyn 2011; 30: 447-55.
31. Tamaki T, Uchiyama Y, Okada Y et al. Functional recovery of damaged skeletal muscle through synchronized vasculogenesis, myogenesis, and neurogenesis by muscle-derived stem cells. Circulation 2005; 112: 2857-66.
32. Maltais S, Tremblay JP, Perrault LP, Ly HQ. The paracrine effect: pivotal mechanism in cell-based cardiac repair. J Cardiovasc Trans Res 2010; 3: 652-62.
33. Parekkadan B, Milwid JM. Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 2010; 15: 87-117.
34. Sassoli C, Pini A, Mazzanti B et al. Mesenchymal stromal cells affect cardiomyocyte growth through juxtacrine Notch-1/Jagged-1 signaling and paracrine mechanisms: clues for cardiac regeneration. J Mol Cell Card 2010; 51: 399-408.